LAX.SH
ALBERT DAVID LIMITED·PHARMACEUTICALS 70.24·Pharmaceuticals & Biotechnology Companies
Price
864.15
+0.11%52W Range
Market Cap
₹493.18 Cr
Traded: ₹0.72 Cr (0.15%) 0.0x
Free Float: ₹175.38 Cr (0.41% of FF traded)
Volume · 60D trend
8.33 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +0.0% | +6.0% | -1.0% | -- | +11.0% | Stable |
| ROE | +9.0% | +10.0% | +8.0% | -- | -- | Stable |
| Return | +9.0% | +6.0% | -4.0% | -10.0% | -- | Decelerating |
| Profit | -- | -- | -- | -- | +259.0% | -- |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 101 | 86 | 90 | 87 | 71 | 75 | 83 | 98 | 89 | 89 | 88 | 93 | 92 | 81 |
| Expenses | 91 | 83 | 79 | 85 | 81 | 80 | 82 | 92 | 88 | 79 | 80 | 77 | 79 | 72 |
| Operating Profit | 11 | 3 | 11 | 3 | -11 | -5 | 1 | 6 | 1 | 10 | 8 | 16 | 13 | 10 |
| OPM % | 10.0% | 3.2% | 12.0% | 2.9% | -15.0% | -6.0% | 0.8% | 6.0% | 1.0% | 11.0% | 9.0% | 17.0% | 14.0% | 12.0% |
| Other Income | 28 | -25 | 12 | -2 | 22 | -5 | -9 | 21 | 23 | 10 | 17 | 12 | 18 | 0 |
| Interest | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 |
| Profit Before Tax | 36 | -25 | 20 | -3 | 8 | -12 | -10 | 25 | 22 | 18 | 23 | 27 | 29 | 7 |
| Tax % | 11.0% | -15.0% | 23.0% | 28.0% | 6.0% | -13.0% | -8.0% | 28.0% | 15.0% | 29.0% | 20.0% | 24.0% | 20.0% | 48.0% |
| Net Profit | 32 | -21 | 15 | -3 | 8 | -10 | -9 | 18 | 19 | 13 | 19 | 20 | 23 | 4 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 56.1 | -37.5 | 26.8 | -5.8 | 13.9 | -18.1 | -16.4 | 31.7 | 33.0 | 22.6 | 32.8 | 35.6 | 41.2 | 6.5 |
| Sales Growth (YoY) | 42.3% | 14.7% | 8.4% | -11.2% | -20.2% | -15.7% | -5.7% | 5.4% | -3.3% | 9.9% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 17.4% | -4.4% | 3.5% | 22.5% | -5.3% | -9.6% | -15.3% | 10.1% | 0.0% | 1.1% | -5.4% | 1.1% | 13.6% | -- |
| OP Growth (YoY) | 200.0% | 160.0% | 1000.0% | -50.0% | -1200.0% | -150.0% | -87.5% | -62.5% | -92.3% | 0.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | 266.7% | -72.7% | 266.7% | 127.3% | -120.0% | -600.0% | -83.3% | 500.0% | -90.0% | 25.0% | -50.0% | 23.1% | 30.0% | -- |
| Profit Growth (YoY) | -- | -107.0% | 263.0% | -118.0% | -58.0% | -180.0% | -150.0% | -11.0% | -20.0% | 246.0% | 77.0% | 1.0% | 1235.0% | -11.0% |
| EPS Growth (YoY) | 303.1% | -107.5% | 263.0% | -118.3% | -57.9% | -180.0% | -150.2% | -11.0% | -19.8% | 245.9% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 249.3% | -240.1% | 563.8% | -141.6% | 176.8% | -10.0% | -152.0% | -4.1% | 45.9% | -31.0% | -7.8% | -13.6% | 529.4% | -- |
| OP Margin | 10.9% | 3.5% | 12.2% | 3.5% | -15.5% | -6.7% | 1.2% | 6.1% | 1.1% | 11.2% | 9.1% | 17.2% | 14.1% | 12.3% |
| Net Margin | 31.7% | -24.4% | 16.7% | -3.5% | 11.3% | -13.3% | -10.8% | 18.4% | 21.4% | 14.6% | 21.6% | 21.5% | 25.0% | 4.9% |
| Material Cost % | -- | 35.0% | 30.9% | 35.1% | 35.8% | 39.2% | 31.7% | 30.8% | 33.9% | 33.3% | 37.4% | 34.0% | 34.5% | 37.7% |
| Employee Cost % | -- | 26.9% | 26.6% | 31.0% | 40.3% | 30.3% | 34.4% | 29.8% | 31.8% | 25.5% | 26.2% | 21.9% | 24.1% | 21.2% |
| P/S | 1.35 | 1.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 21.85 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.26 | 1.01 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Newspaper Publication regarding extract of unaudited financial results for the first quarter ended 30th June, 2026
Scrutinizer''s Report for 87th Annual General Meeting
Voting Results for the 87th Annual General Meeting of the Company
Intimation under Regulation 30 - Resignation of Senior Managerial Personnel
Outcome of Board Meeting dated 06.08.2026 regarding approval of Unaudited Financial Results for quarter ended 30th June, 2026
Proceedings of 87th Annual General Meeting
Albert David Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve To consider, approve and take ....
Pursuant to Regulations 36(1)(b) of SEBI Listing Regulations, 2015, the Company has completed the dispatch of the letters containing the web-link of the Annual Report to those members whose ....
Newspaper Publication dated 14.07.2026 regarding 87th AGM Notice dispatch along with Annual Report F.Y. 2025-26 to shareholders electronically and also via web-link letter to shareholders ....
Notice of 87th AGM along with Annual Report for F,Y 2025-26
87th AGM has been scheduled on 6th August, 2026 at 9:30 A.M.
Submission of Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Resignation of Senior Managerial Personnel
Enclosed herewith copy of Newspaper Publication regarding Notice issued for attention of the shareholders in respect of information regarding 87th Annual General Meeting scheduled to be ....
Credit Rating from CARE EDGE Ratings as on 26.06.2026.
Closure of Trading Window from Wednesday 1st July, 2026 for declaration of Unaudited Financial statement for quarter ended 30th June 2026
Appointment of Mr. Amit Mahla as Additional Director and Whole-time Director & CEO w.e.f 19th June 2026
Appointment of Mr. Amit Mahla as an Additional Director and Whole-time Director & CEO of the Company and fixed his remuneration. Revised Notice of 87th AGM.
Disclosure pursuant to Reg. 30 - Publication of Notice in Newspapers for transfer of equity shares of the Company to the Investor Education and Protection Fund
Resignation of Senior Managerial Personnel
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026
Newspaper publication of Extract of Audited Financial Result for the fourth quarter and year ended 31st March, 2026
Integrated Filing Financials for the fourth quarter and year ended 31st March 2026
Regulation 30(5) of SEBI ( LODR), 2015 KMP''S authorised to determine materiality under Regulation 30(5) of SEBI (LODR), 2015
Book closure date
Record date fixed on 30th July 2026 for the purpose of final dividend and determining members eligible to vote for 87th AGM.
Board approves final dividend at Rs. 5.00 for the F.Y. 2025-26
Re-appointment of Cost Auditors for the F.Y. 2026-27
Financial Results for the Fourth quarter and year ended 31st March, 2026
Change in Management
Outcome of Board Meeting dated 12th May, 2026 to consider and approve Intimation of Board Meeting to consider and approve the Audited Financial Results of the Company for the fourth quarter ....
Re-appointment of Internal Auditors for the F.Y. 2026-27
Albert David Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....
Submission of Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Closure of Trading Window from Wednesday, 1st April, 2026 for declaration of Audited Financial Results for the quarter and financial year ended 31st March, 2026
Re-lodgement of transfer of 300 Nos. of Physical Equity Shares by Mr. Bharat Kumar N Jain as per SEBI Circular No. SEBI/HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated 30th January, 2026
Newspaper Publication regarding special window for re-lodgement of transfer requests of physical shares
Resignation of Senior Managerial Personnel (Change in Management)
Newspaper Publication of Extract of Unaudited Financial Result for the third quarter and nine months ended 31st December, 2025
To consider, approve and take on record the Unaudited Financial Results for the third quarter and nine months ended 31st December, 2025
To consider, approve and take on record the Unaudited Financial Results for the third quarter and nine months ended 31st December, 2025
Albert David Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve To consider and approve Unaudited ....
Change in Senior Management Personnel-Disclosure under Reg. 30 read with Schedule III of SEBI (LODR) Reg., 2015
Submission of Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Closure of Trading Window from 1st January, 2026 for declaration of Unaudited Financial Results for the third quarter and nine months period ended 31st December, 2025
Closure of Trading window from 1st January, 2026 for declaration of Unaudited Financial Results for the third quarter and nine months period ended 31st December, 2025
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Resignation of Managing Director, CEO & Director
Resignation of Mr. Umesh Manohar Kunte as Director w.e.f 18-12-2025.
Resignation of Mr. Umesh Manohar Kunte as Chief Executive officer w.e.f 18-12-2025.
Resignation of Mr. Umesh Manohar Kunte, Managing Director w.e.f. 18-12-2025.
Annual Reports
16